THE PRODUCT IS THE PRODUCT
Live / Registered — Registered (as of 05 Mar 2024)
What this means for you
Registered since 05 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97440683
- Registration number
- 7323734
- Mark type
- Stylized text
- Filed
- 02 Jun 2022
- Published for opposition
- 09 May 2023
- Registered
- 05 Mar 2024
- Attorney of record
- Trevor P. Schmidt
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of cell and gene therapies for others
- Class 042 — Scientific and technological services: Research and testing services in support of gene and cell therapy development, namely, biotechnology research, pharmaceutical drug development and research services focused on pharmaceutical drug formulation and testing, and pharmacology research; research and testing services in support of gene and cell therapy development, namely, conducting research and clinical trials for others relating to biotechnology, pharmaceutical drug formulation and testing, and pharmacology
Owner
- AMPLIFYBIO, LLC, WEST JEFFERSON, OH, US
- AMPLIFYBIO, LLC, WEST JEFFERSON, OH, US
- AMPLIFYBIO, LLC, WEST JEFFERSON, OH, US
Prosecution history
- 07 May 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 05 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 30 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Jan 2024 — USE AMENDMENT FILED
- 24 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 04 Jul 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 May 2023 — PUBLISHED FOR OPPOSITION
- 19 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED